LT - Peroraliai aktyvaus 1,2,4-oksadiazolo, skirto nonsense tipo mutacijų supresijos terapijai, dozavimo būdai
EN - METHODS FOR DOSING AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/4245 |
(2006.01) |
|
|
A61P 3/10 |
(2006.01) |
|
|
A61P 7/00 |
(2006.01) |
|
|
A61P 9/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
2073805 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
07852738.9 |
|
Date of filing the European patent application |
2007-10-11 |
| (97) |
Date of publication of the European application |
2009-07-01 |
| (45) |
Date of publication and mention of the grant of the patent |
2015-03-04
|
| (46) |
Date of publication of the claims translation |
2015-07-27
|
PCT application
| (86) |
Number |
PCT/US2007/021921 |
|
Date |
2007-10-11 |
PCT application publication
| (87) |
Number |
WO 2008/045566 |
|
Date |
2008-04-17 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
851450 P |
2006-10-12
|
US |
Inventors
| (72) |
HIRAWAT, Samit, US
MILLER, Langdon, US
|
Grantee
| (73) |
PTC Therapeutics, Inc.,
100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080,
US
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
Peroraliai aktyvaus 1,2,4-oksadiazolo, skirto nonsense tipo mutacijų supresijos terapijai, dozavimo būdai |
| |
METHODS FOR DOSING AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2023-09-20 |
17 |
347.00
EUR
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2024-10-11 |
